- Home
- SIGA vs HPI Comparison
SIGA vs HPI Comparison
Compare SIGA & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- HPI
- Stock Information
- Founded
- SIGA 1995
- HPI 2002
- Country
- SIGA United States
- HPI United States
- Employees
- SIGA N/A
- HPI N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- HPI Trusts Except Educational Religious and Charitable
- Sector
- SIGA Health Care
- HPI Finance
- Exchange
- SIGA Nasdaq
- HPI Nasdaq
- Market Cap
- SIGA 422.9M
- HPI 421.3M
- IPO Year
- SIGA 1997
- HPI N/A
- Fundamental
- Price
- SIGA $6.77
- HPI $16.06
- Analyst Decision
- SIGA
- HPI
- Analyst Count
- SIGA 0
- HPI 0
- Target Price
- SIGA N/A
- HPI N/A
- AVG Volume (30 Days)
- SIGA 382.0K
- HPI 64.7K
- Earning Date
- SIGA 07-31-2025
- HPI 01-01-0001
- Dividend Yield
- SIGA 8.70%
- HPI 8.97%
- EPS Growth
- SIGA N/A
- HPI N/A
- EPS
- SIGA 0.67
- HPI N/A
- Revenue
- SIGA $120,330,310.00
- HPI N/A
- Revenue This Year
- SIGA N/A
- HPI N/A
- Revenue Next Year
- SIGA $95.31
- HPI N/A
- P/E Ratio
- SIGA $10.28
- HPI N/A
- Revenue Growth
- SIGA N/A
- HPI N/A
- 52 Week Low
- SIGA $4.95
- HPI $12.85
- 52 Week High
- SIGA $12.83
- HPI $16.83
- Technical
- Relative Strength Index (RSI)
- SIGA 61.28
- HPI 62.30
- Support Level
- SIGA $6.34
- HPI $16.08
- Resistance Level
- SIGA $7.07
- HPI $16.26
- Average True Range (ATR)
- SIGA 0.22
- HPI 0.14
- MACD
- SIGA 0.02
- HPI 0.04
- Stochastic Oscillator
- SIGA 71.70
- HPI 96.67
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.